Skip Nav Destination
Benefits and risks of JAK inhibition
Non-zero-sum game of transfusions: EOL in leukemia
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)
Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study
Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment
Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine
Issue Archive
Table of Contents
BLOOD COMMENTARIES
CLINICAL TRIALS AND OBSERVATIONS
Benefits and risks of JAK inhibition
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
Non-zero-sum game of transfusions: EOL in leukemia
Clinical Trials & Observations
PERSPECTIVE
BLOOD SPOTLIGHT
CLINICAL TRIALS AND OBSERVATIONS
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
Clinical Trials & Observations
Edit Porpaczy,Sabrina Tripolt,Andrea Hoelbl-Kovacic,Bettina Gisslinger,Zsuzsanna Bago-Horvath,Emilio Casanova-Hevia,Emmanuelle Clappier,Thomas Decker,Sabine Fajmann,Daniela A. Fux,Georg Greiner,Sinan Gueltekin,Gerwin Heller,Harald Herkner,Gregor Hoermann,Jean-Jacques Kiladjian,Thomas Kolbe,Christoph Kornauth,Maria-Theresa Krauth,Robert Kralovics,Leonhard Muellauer,Mathias Mueller,Michaela Prchal-Murphy,Eva Maria Putz,Emmanuel Raffoux,Ana-Iris Schiefer,Klaus Schmetterer,Christine Schneckenleithner,Ingrid Simonitsch-Klupp,Cathrin Skrabs,Wolfgang R. Sperr,Philipp Bernhard Staber,Birgit Strobl,Peter Valent,Ulrich Jaeger,Heinz Gisslinger,Veronika Sexl
Publisher's Note: There is a Blood Commentary on this article in this issue.
Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)
Clinical Trials & Observations
Hervé Decousus,Aurélie Bourmaud,Pierre Fournel,Laurent Bertoletti,Carine Labruyère,Emilie Presles,Adel Merah,Silvy Laporte,Laetitia Stefani,Francesco Del Piano,Jean-Philippe Jacquin,Guy Meyer,Franck Chauvin,for the ONCOCIP Investigators
Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia
Clinical Trials & Observations
LYMPHOID NEOPLASIA
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations
e-blood
Sarah C. Rutherford,Angela A. Fachel,Sheng Li,Seema Sawh,Ashlesha Muley,Jennifer Ishii,Ashish Saxena,Pilar M. Dominguez,Eloisi Caldas Lopes,Xabier Agirre,Nyasha Chambwe,Fabian Correa,Yanwen Jiang,Kristy L. Richards,Doron Betel,Rita Shaknovich
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell engraftment
Simranpreet Kaur,Liza J. Raggatt,Susan M. Millard,Andy C. Wu,Lena Batoon,Rebecca N. Jacobsen,Ingrid G. Winkler,Kelli P. MacDonald,Andrew C. Perkins,David A. Hume,Jean-Pierre Levesque,Allison R. Pettit
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study
CME
Clinical Trials & Observations
Brief Report
Regis Peffault de Latour,Sylvie Chevret,Charlotte Jubert,Anne Sirvent,Claire Galambrun,Annalisa Ruggeri,Virginie Gandemer,Jérôme Cornillon,Fanny Rialland,Jean-Hugues Dalle,Edouard Forcade,Benedicte Bruno,Catherine Paillard,Pierre S. Rorlich,Alexandra Salmon,Sabine Fürst,Flore Sicre de Fontbrune,Marie Therese Rubio,Jacques-Olivier Bay,Mohamad Mohty,Jerome Larghero,Eliane Gluckman,Gerard Socié,on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
LETTERS TO BLOOD
Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation
Clinical Trials & Observations
CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment
Clinical Trials & Observations
Yuma Sakamoto,Takashi Ishida,Ayako Masaki,Takayuki Murase,Kentaro Yonekura,Yukie Tashiro,Masahito Tokunaga,Atae Utsunomiya,Asahi Ito,Shigeru Kusumoto,Shinsuke Iida,Ryuzo Ueda,Hiroshi Inagaki
Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine
Clinical Trials & Observations
Richa Manwani,Sajitha Sachchithanantham,Shameem Mahmood,Darren Foard,Faye Sharpley,Tamer Rezk,Thirusha Lane,Cristina Quarta,Marianna Fontana,Helen J. Lachmann,Julian D. Gillmore,Carol Whelan,Philip N. Hawkins,Ashutosh D. Wechalekar
BLOOD WORK
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
-
Cover Image
Cover Image
Hematoxylin and eosin–stained peripheral blood smear from Stat1−/− mice. Notice the expansion of myeloid cells indicating a myeloproliferative disease. Stat1−/− mice develop a myeloid hyperplasia as they age. Transplantation of bone marrow from diseased Stat1−/− mice provokes the outgrowth of an aggressive B-cell clone in recipient mice that is already detectable in the donor Stat1−/− mice. See the article by Porpaczy et al on page 694.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals